-
Patent Agency Ranking
公开(公告)号：US20130090341A1
公开(公告)日：2013-04-11
申请号：US13633995
申请日：2012-10-03
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Tatsuki KOIKE , Masato YOSHIKAWA , Haruhi KAMISAKI , William John FARNABY
IPC: C07D401/10 , C07D413/14 , C07D401/14 , A61K31/506 , A61P25/16 , A61K31/501 , C07D413/10 , A61K31/454 , A61P25/28 , A61K31/4545 , C07D417/14
CPC classification number: C07D498/08 , C07D401/10 , C07D401/14 , C07D405/10 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/14
Abstract: The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Abstract translation: 本发明提供可用作预防或治疗神经变性疾病等的药剂或其盐。 本发明涉及由下式表示的化合物，其中每个符号如说明书中所定义，或其盐。
-
公开(公告)号：US20130303553A1
公开(公告)日：2013-11-14
申请号：US13944370
申请日：2013-07-17
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Takahiko TANIGUCHI , Masato YOSHIKAWA , Kasei MIURA , Tomoaki HASUI , Eiji HONDA , Keisuke IMAMURA , Makoto KAMATA , Haruhi KAMISAKI
IPC: C07D471/04 , C07D473/00 , C07D498/04
CPC classification number: A61K31/4353 , A61K31/4355 , A61K31/437 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/4985 , A61K31/5025 , A61K31/519 , A61K31/52 , A61K31/522 , A61K31/551 , C07D401/14 , C07D403/04 , C07D403/14 , C07D413/14 , C07D471/04 , C07D471/14 , C07D473/00 , C07D473/28 , C07D487/04 , C07D495/04 , C07D498/04 , C07D498/08 , C07D519/00 , C07F7/10
Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): wherein the symbols are defined in the specification.
Abstract translation: 本发明提供具有PDE抑制作用的化合物，其可用作预防或治疗精神分裂症的药剂。 化合物由式（I）表示：其中符号在说明书中定义。
-
公开(公告)号：US20140088118A1
公开(公告)日：2014-03-27
申请号：US13944042
申请日：2013-07-17
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： Tatsuki KOIKE , Masato YOSHIKAWA , Haruhi KAMISAKI , William John FARNABY
IPC: C07D401/14
CPC classification number: C07D498/08 , C07D401/10 , C07D401/14 , C07D405/10 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/14
Abstract: The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
-
4.发明申请公开(公告)号：US20140228320A1
公开(公告)日：2014-08-14
申请号：US14253139
申请日：2014-04-15
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Takahiko TANIGUCHI , Masato YOSHIKAWA , Kasei MIURA , Tomoaki HASUI , Eiji HONDA , Keisuke IMAMURA , Makoto KAMATA , Haruhi KAMISAKI , John F. QUINN , Joseph RAKER , Fatoumata CAMARA , Yi WANG
IPC: C07D471/04 , C07D471/14 , C07D487/04 , C07D498/04 , C07F7/10
CPC classification number: A61K31/4353 , A61K31/4355 , A61K31/437 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/4985 , A61K31/5025 , A61K31/519 , A61K31/52 , A61K31/522 , A61K31/551 , C07D401/14 , C07D403/04 , C07D403/14 , C07D413/14 , C07D471/04 , C07D471/14 , C07D473/00 , C07D473/28 , C07D487/04 , C07D495/04 , C07D498/04 , C07D498/08 , C07D519/00 , C07F7/10
Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):
Abstract translation: 本发明提供具有PDE抑制作用的化合物，其可用作预防或治疗由式（I）表示的精神分裂症等的药剂：
-
公开(公告)号：US20140088146A1
公开(公告)日：2014-03-27
申请号：US13944000
申请日：2013-07-17
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： Tatsuki KOIKE , Masato YOSHIKAWA , Haruhi KAMISAKI , William John FARNABY
IPC: C07D401/14
CPC classification number: C07D498/08 , C07D401/10 , C07D401/14 , C07D405/10 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/14
Abstract: The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Abstract translation: 本发明提供可用作预防或治疗神经变性疾病等的药剂或其盐。 本发明涉及由下式表示的化合物，其中每个符号如说明书中所定义，或其盐。
-
-
-
-
Search Results
5
records
(took 0.024 seconds)
